Protalix BioTherapeutics (PLX) Reports Q2 Loss of $0.16
Tweet
Share
E-mailGet Alerts PLX Hot Sheet
Price: $2.67 --0%
Revenue Growth %: -15.8%
Financial Fact:
NET LOSS FOR THE PERIOD: -7.29M
Today's EPS Names:
FIZZ, IMPP, RH, More
Revenue Growth %: -15.8%
Financial Fact:
NET LOSS FOR THE PERIOD: -7.29M
Today's EPS Names:
FIZZ, IMPP, RH, More
Join SI Premium – FREE
Protalix BioTherapeutics (NYSE: PLX) reported Q2 EPS of ($0.16). Revenue for the quarter came in at $24.84 million versus the consensus estimate of $10.22 million.
For earnings history and earnings-related data on Protalix BioTherapeutics (PLX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Cooper Cos. (COO) Tops Q3 EPS by 3c, Offers Guidance
- Piper Sandler Starts AMD (AMD) at Overweight
- Piper Sandler Starts Qualcomm (QCOM) at Neutral
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
